ECRI and the Institute for Safe Medication Practices (ISMP) Patient Safety Organization (PSO) convened an interdisciplinary pressure-injury-prevention safety collaborative to strengthen pressure injury assessment, prevention, and treatment planning. Several teams met over 5 months in 2023 to share knowledge and performance improvement tools. This article discusses the safety collaborative, which provided a learning-system platform for participating teams to develop and share improvement plans under the protection of the PSO and to strengthen their pressure-injury-related action plans.
View Article and Find Full Text PDFUnlabelled: The amount of residual dentin thickness and tooth position in the dental arch is crucial to determine whether an intraradicular post should be used. This study aimed to compare stress distribution on the root dentin of an endodontically treated tooth rehabilitated with CAD/CAM milled glass fiber posts (MP), cast metal posts (CMP), or prefabricated posts (PP) with or without ferrule support, using the finite element method.
Materials And Methods: A human upper central incisor was selected, scanned, and treated endodontically.
Importance: The psychological morbidity experienced by physicians, advanced practice practitioners (APPs), and nurses from working during the COVID-19 pandemic includes burnout, depression, and posttraumatic stress disorder (PTSD).
Objective: To investigate whether psilocybin therapy could improve symptoms of depression, burnout, and PTSD in US clinicians who developed these symptoms from frontline clinical work during the pandemic.
Design, Setting, And Participants: This double-blind randomized clinical trial enrolled participants from February to December 2022.
Purpose: Evaluate the relationship between first and second-line medication dosing and progression to refractory status epilepticus (RSE) in children.
Methods: This is a retrospective analysis of prospectively collected data from September 2014 to February 2020 of children with status epilepticus (SE) who received at least two antiseizure medications (ASMs). We evaluated the risk of developing RSE after receiving a low total benzodiazepine dose (lower than 100 % of the minimum recommended dose for each benzodiazepine dose administered within 10 min) and a low first non-benzodiazepine ASM dose (lower than 100 % of the minimum recommended dose of non-benzodiazepine ASM given as the first single-dose) using a logistic regression model, adjusting for confounders such as time to ASMs.